Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 1.38 USD 0.36% Market Closed
Market Cap: 15.8m USD

Wall Street
Price Targets

CLGN Price Targets Summary
Collplant Biotechnologies Ltd

Wall Street analysts forecast CLGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLGN is 14.28 USD with a low forecast of 14.14 USD and a high forecast of 14.7 USD.

Lowest
Price Target
14.14 USD
925% Upside
Average
Price Target
14.28 USD
935% Upside
Highest
Price Target
14.7 USD
965% Upside
Collplant Biotechnologies Ltd Competitors:
Price Targets
688520
Sinocelltech Group Ltd
5% Downside
TNG
Transgene SA
98% Upside
BDTX
Black Diamond Therapeutics Inc
363% Upside
STTK
Shattuck Labs Inc
194% Upside
BPMC
Blueprint Medicines Corp
4% Upside
4882
Perseus Proteomics Inc
105% Upside
FYB
Formycon AG
94% Upside
UTHR
United Therapeutics Corp
38% Upside

Revenue
Forecast

Revenue Estimate
Collplant Biotechnologies Ltd

For the last 5 years the compound annual growth rate for Collplant Biotechnologies Ltd's revenue is -26%. The projected CAGR for the next 3 years is 156%.

-26%
Past Growth
156%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Collplant Biotechnologies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Collplant Biotechnologies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLGN's stock price target?
Price Target
14.28 USD

According to Wall Street analysts, the average 1-year price target for CLGN is 14.28 USD with a low forecast of 14.14 USD and a high forecast of 14.7 USD.

What is Collplant Biotechnologies Ltd's Revenue forecast?
Projected CAGR
156%

For the last 5 years the compound annual growth rate for Collplant Biotechnologies Ltd's revenue is -26%. The projected CAGR for the next 3 years is 156%.

Back to Top